NCT06350734Active, not recruiting
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
This study evaluates the effect of bladder cancer treatment on quality of life.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 204 (actual)
- First submitted
- 2 Apr 2024
- Start date
- 12 Oct 2018
- Primary completion date
- 31 Jan 2029
- Lead sponsor
- Mayo Clinic
- Diseases
- Bladder cancer
- NCT number
- NCT06350734
What you commit to
- Study type: Observational
- Participants enrolled: 204
- From 12 Oct 2018 to the primary completion date, 31 Jan 2029
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Does not meet inclusion criteria
Who the study is looking for
- Have pathologically confirmed, clinically localized, bladder cancer
- Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
- Able to give consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Florida Coordinator of this site? Confirm its status | Jacksonville | United States | Unknown status |
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
| Mayo Clinic in Arizona Coordinator of this site? Confirm its status | Scottsdale | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.